DAPK-IN-2

CAS No. 304000-05-3

DAPK-IN-2( —— )

Catalog No. M36987 CAS No. 304000-05-3

DAPK-IN-2 (WAY-380496) is a DAPK inhibitor. DAPK-IN-2 has potential anticancer activity, regulates autophagy and can be used to study cerebral infarction and ischemic diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 141 Get Quote
5MG 217 Get Quote
10MG 337 Get Quote
25MG 544 Get Quote
50MG 724 Get Quote
100MG 963 Get Quote
500MG 1917 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DAPK-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    DAPK-IN-2 (WAY-380496) is a DAPK inhibitor. DAPK-IN-2 has potential anticancer activity, regulates autophagy and can be used to study cerebral infarction and ischemic diseases.
  • Description
    DAPK-IN-2 is a DAPK inhibitor. DAPK-IN-2 can be used for the research of cerebral infarction and ischemic diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    DAPK
  • Recptor
    DAPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    304000-05-3
  • Formula Weight
    310.3
  • Molecular Formula
    C17H14N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 2 mg/mL (6.45 mM; Ultrasonic (<60°C)
  • SMILES
    COC1=C(OC)C=C(C=C1)C1=N\C(=C\C2=CC=CN=C2)C(=O)O1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Okamoto M, et al. Structure-activity relationship of novel DAPK inhibitors identified by structure-based virtual screening. Bioorg Med Chem. 2010;18(7):2728-2734. ?
molnova catalog
related products
  • DAPK-IN-2

    DAPK-IN-2 (WAY-380496) is a DAPK inhibitor. DAPK-IN-2 has potential anticancer activity, regulates autophagy and can be used to study cerebral infarction and ischemic diseases.

  • HS94

    HS94 (DAPK3 inhibitor HS94) is a selective DAPK3 inhibitor with Ki of 126 nM, >20-fold selectivity over Pim kinases.

  • DRAK2-IN-16

    DRAK2-IN-116 is a potent, selective DRAK2 inhibitor with IC50 of 3 nM.